Lite Strategy (LITS) closed at $0.86 on November 16, 2026, up 1.1% from the previous close, on volume of 291,686 shares (30-day average 323,335).
Data as of November 16, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 16, 2026. See the largest for 5, 30, 60 and 90 days
No headlines found.
Lite Strategy Reports Fiscal 2027 First Quarter Financial Results
Globe Newswire (Tue, 10-Nov 8:30 AM ET)
Lite Strategy Marks 15 Years of Litecoin with Launch of "Proof of Time" Public Industry Archive
Globe Newswire (Tue, 13-Oct 1:41 PM ET)
Lite Strategy Reports Fiscal Year 2026 Financial Results
Globe Newswire (Tue, 29-Sep 8:30 AM ET)
Lite Strategy to Present at the 28th Annual H.C. Wainwright Global Investment Conference in New York
Globe Newswire (Thu, 10-Sep 9:00 AM ET)
Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor, and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients. The company operates in the segments: Digital Asset Treasury Strategy and Development of Pharmaceutical Products.
Lite Strategy trades on the NASDAQ stock market under the symbol LITS.
As of November 17, 2026, LITS stock price declined to $0.77 with 110,436 million shares trading.
LITS has a beta of 1.05, meaning it tends to be more sensitive to market movements. LITS has a correlation of 0.04 to the broad based SPY ETF.
LITS has a market cap of $23.41 million. This is considered a Sub-Micro Cap stock.
The top ETF exchange traded funds that LITS belongs to (by Net Assets): VTI, VXF, IWC.
LITS has underperformed the market in the last year with a price return of -61.9% while the SPY ETF gained +9.9%. LITS has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -13.1% and -20.4%, respectively, while the SPY returned -5.6% and -2.8%, respectively.
LITS support price is $.81 and resistance is $.91 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LITS shares will trade within this expected range on the day.